Advanced Ultrasound Applications for Predicting AVF Outcomes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

75 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-11-01

Study Completion Date

2024-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Haemodialysis is a renal replacement therapy that can be introduced to patients with end-stage renal disease (ESRD) to help them maintain a good healthy life. The patient's blood is pumped through a dialysis machine to remove excess fluid, salt and waste, then it is pumped back into the patient's circulation system. In order to carry out haemodialysis, vascular access (VA) is required to connect the patient to the dialysis machine. Patients have only three options of vascular access: arteriovenous fistula (AVF), an anastomosis between a native vein and an artery; arteriovenous graft (AVG), a connection between a synthetic tube and native blood vessels; and (3) central line, a cuffed catheter placed in a large neck vein. Arteriovenous fistulas are the preferred method for VA because of their longevity and causing the least number of complications. Although there are a number of factors that may increase the probability of AVF failure rate such as age and gender of the patient, poor native vessel structure, medications and the level of surgical experience, 30-40% of new AVFs fail to mature for unknown reasons. For an AVF to become functionally mature postoperative, remodelling and dilation of the native artery and vein are essential to accommodate significantly increased blood flow. However, pre-existing diseases in patients with ESRD such as arterial stiffness and endothelial dysfunction may impair AVF and preclude dialysis. It has been asserted that the lack of AVF success is attributable to insufficient arterial dilation because of poor arterial wall elasticity.

The study aims to investigate the role of arterial stiffness and endothelial dysfunction in predicting AVF outcome using novel non-invasive ultrasound applications: 2D shear wave elastography and 2D strain speckle tracking will be employed to assess arterial stiffness, while an intraoperative flow-mediated dilation (FMD) technique will be used to evaluate endothelial dysfunction.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Sonographic Venous Doppler Imaging in End-Stage Renal Disease

NCT05337384

Emergent Dialysis Venous Doppler Ultrasound

COMPLETED

Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury

NCT04095143

Acute Kidney Injury Fluid Overload Ultrasonography

COMPLETED

The Effect of Ultrasonography on Blood Flow,Vessel Diameter,and Depth Measurements in Dialysis Patients With Fistula

NCT06262659

Arteriovenous Fistula

COMPLETED

Application of Ultrasound Integrated Precision Diagnosis Technology in Prevention of Kidney Disease and Its Progress

NCT04044404

Diagnostic Imaging Diagnosis Kidney Disease

COMPLETED

Establishing a New Ultrasound Technique to Improve Assessment of Chronic Kidney Disease.

NCT06159439

Chronic Kidney Diseases

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is an observational prospective pilot study of patients with end-stage renal disease (ESRD), who will be referred for AVF procedure.

Duration: 21 Months The research team will collect data from the patients after they have signed the informed consent form. Data collection will take place before, during and after arteriovenous fistula (AVF) surgery.

At 0 week, the patient will be interviewed to obtain clinical information. Also, blood pressure and body mass index will be checked and recorded. Next, pre-operative AVF assessment ultrasound measurements will be performed to assess flow, pulsatility and vessel diameter. Advanced ultrasound applications(2D strain speckle tracking and 2D Shear wave elastography) will be applied to assess arterial stiffness as additional measurement tools. These are quantitative measures of vessel stiffness. It takes less than five minutes to obtain these measurements from the imaged vessel.

During AVF surgery, the endothelial function will be assessed intraoperatively by testing the ability of the endothelium to dilate, flow mediation dilation (FMD). Leftover vessel specimens will be collected for histopathological analysis purpose.

At 6 week, post-AVF ultrasound assessment will be conducted to assess the maturation of AVF by measuring ultrasound parameters of blood flow, pulsatility and vessel diameter. Arterial stiffness parameters will be measured as well. Blood pressure and BMI will be assessed and recorded.

Study data will be entered into a study database which will consist of a password encrypted stored on a password-protected computer in the vascular lab at Hammersmith Hospital. Only the study researchers will know the study database password.

Data analysis will be performed after the enrolment of 20, 40 and 75 patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End Stage Renal Diseases Renal Failure Chronic Kidney Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study group

Patients with end-stage renal disease who will undergo arteriovenous fistula (AVF) surgery will be recruited and follow-up them up to 6 weeks or until the AVF become suitable for hemodialysis.

Advanced ultrasound measurements

Intervention Type DIAGNOSTIC_TEST

Clinical interventions and procedures:

* Consent at 0 week
* Clinical data collection at 0 week
* Strain for native artery at 0 week
* Young's modulus for native artery at 0 week
* Intimal medial thickness for native artery at 0 week
* Ultrasound blood volume flow measurement at 0 week
* Vessel diameter at 0 week
* Blood pressure at 0 week
* BMI at 0 week
* Intra-operative blood volume flow measurement at AVF surgery time
* Strain for native artery at 6 weeks
* Young's modulus native artery at 6 weeks
* Intimal medial thickness native artery arteries at 6 weeks
* Ultrasound blood volume flow measurement at 6 weeks
* Vessel diameter at 6 weeks
* Blood pressure at 6 weeks
* BMI at 6 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Advanced ultrasound measurements

Clinical interventions and procedures:

* Consent at 0 week
* Clinical data collection at 0 week
* Strain for native artery at 0 week
* Young's modulus for native artery at 0 week
* Intimal medial thickness for native artery at 0 week
* Ultrasound blood volume flow measurement at 0 week
* Vessel diameter at 0 week
* Blood pressure at 0 week
* BMI at 0 week
* Intra-operative blood volume flow measurement at AVF surgery time
* Strain for native artery at 6 weeks
* Young's modulus native artery at 6 weeks
* Intimal medial thickness native artery arteries at 6 weeks
* Ultrasound blood volume flow measurement at 6 weeks
* Vessel diameter at 6 weeks
* Blood pressure at 6 weeks
* BMI at 6 weeks

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \>18 years age
* \<90 years age
* End stage renal disease
* Glomerular filtration rate \< 30 ml/min/1.73m2

Exclusion Criteria

* \<18 years age
* \> 90 years age
* \< 2cm vein diameter
* Not end-stage renal disease
* Pregnant patients will not be recruited in this study. Patients pregnancy status will be assessed on initial enrolment to exclude them from the study.
* Those unable to provide consent.
* Anyone who is taking part in any other research.
* Potential participants who might not adequately understand verbal explanations or written information given in English, or who have special communication needs will not be included

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes